HER2-Positive Breast Cancer: Current and Future Treatment Strategies

By Engel Ryan H.   Kaklamani Virginia G.  

Drugs, Vol. 67, Iss. 9, 2007-01 ,pp. : 1329-1341

Adis International

Access to resources Recommend Favorite

Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer

By  

Current Cancer Drug Targets, Vol. 9, Iss. 2, 2009-03 ,pp. : 148-162

Bentham Science Publishers

Access to resources Recommend Favorite

Pertuzumab: In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer

By Keating Gillian M.  

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 353-360

Adis International

Access to resources Recommend Favorite

Mechanisms of Adipocytokine-Mediated Trastuzumab Resistance in HER2-Positive Breast Cancer Cell Lines

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 1, 2013-03 ,pp. : 31-41

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer

By Hare Jennifer I.   Moase Elaine H.   Allen Theresa M.  

Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. : 87-96

Informa Healthcare

Access to resources Recommend Favorite